M C Oliveira Selected Research

M C Oliveira Research Topics

Disease

8	Neoplasms (Cancer) 04/2021 - 05/2002
4	Pituitary Neoplasms (Pituitary Adenoma) 12/2017 - 09/2000
3	Adenoma (Adenomas) 12/2017 - 05/2002
2	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2013
2	Multiple Sclerosis 01/2017 - 02/2010
2	Meningioma (Meningiomas) 01/2016 - 05/2015
2	Systemic Scleroderma (Systemic Sclerosis) 01/2016 - 01/2016
2	Infections 12/2012 - 04/2004
2	Carcinoma (Carcinomatosis) 06/2003 - 07/2002
1	Stomach Ulcer (Gastric Ulcer) 06/2019
1	Obesity 06/2019
1	Glucose Intolerance 06/2019
1	Acromegaly 12/2017
1	Growth Hormone-Secreting Pituitary Adenoma 12/2017
1	Carcinogenesis 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2015
1	Brain Death (Brain Dead) 10/2012
1	Fibrosis (Cirrhosis) 10/2007
1	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2007
1	Verrucous Carcinoma 09/2005
1	Papilloma (Papillomatosis) 09/2005
1	Chromosome Inversion (Chromosomal Inversion) 04/2004
1	Leptospirosis 04/2004
1	Thyroid Neoplasms (Thyroid Cancer) 06/2003
1	Leukemia 07/2002
1	Hypertension (High Blood Pressure) 01/2001
1	Hyperprolactinemia 09/2000

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2016 - 05/2002
3	ProlactinIBA 10/2007 - 09/2000
2	Antineoplastic Agents (Antineoplastics)IBA 04/2021 - 12/2018
2	Cadherins (E-Cadherin)IBA 12/2017 - 06/2003
2	Growth Hormone (Somatotropin)IBA 12/2017 - 02/2004
2	GonadotropinsIBA 10/2007 - 02/2004
2	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2004 - 05/2002
1	glucoevatromonosideIBA 04/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2021
1	Pharmaceutical PreparationsIBA 04/2021
1	Liposomes (Liposome)IBA 04/2021
1	CarbohydratesIBA 06/2019
1	Anti-Allergic Agents (Antiallergic Agents)IBA 06/2019
1	Analgesics (Analgesic Drugs)IBA 06/2019
1	Triglycerides (Triacylglycerol)IBA 06/2019
1	ResistinIBA 06/2019
1	Adenosine Triphosphatases (ATPase)IBA 12/2018
1	EnzymesIBA 12/2018
1	CardenolidesIBA 12/2018
1	NitrogenIBA 12/2017
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 12/2017
1	Neurofibromin 2 (Merlin)IBA 01/2016
1	Bombesin Receptors (Bombesin Receptor)IBA 10/2015
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2015
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 05/2015
1	SteroidsIBA 01/2013
1	Steroid Receptors (Steroid Receptor)IBA 01/2013
1	LigandsIBA 01/2013
1	thymoglobulin FDA Link 02/2010
1	Follicle Stimulating Hormone (Follitropin)FDA Link 10/2007
1	Carbon Tetrachloride (Tetrachloromethane)IBA 10/2007
1	Testosterone (Sustanon)FDA Link 10/2007
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2007
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 10/2007
1	Intermediate Filament ProteinsIBA 09/2005
1	Membrane Proteins (Integral Membrane Proteins)IBA 04/2004
1	DNA Transposable Elements (Element, IS)IBA 04/2004
1	VaccinesIBA 04/2004
1	Lipoproteins (Lipoprotein)IBA 04/2004
1	Ki-67 Antigen (Ki 67 Antigen)IBA 02/2004
1	MIB-1 antibodyIBA 02/2004
1	beta CateninIBA 06/2003
1	CateninsIBA 06/2003
1	BiflavonoidsIBA 07/2002
1	DNA TopoisomerasesIBA 07/2002
1	Antihypertensive Agents (Antihypertensives)IBA 01/2001
1	SaltsIBA 01/2001
1	CalciumIBA 01/2001
1	Bromocriptine (Parlodel)FDA LinkGeneric 09/2000

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 04/2021 - 12/2018
2	Hematopoietic Stem Cell Transplantation 01/2016 - 01/2016
1	Radiotherapy 04/2021
1	Therapeutics 04/2021
1	Hypophysectomy 12/2017
1	Stem Cell Transplantation 01/2017
1	Blood Component Transfusion 12/2012
1	Transplantation 10/2012